Multi-Biomarkers Panel in Identifying Benign and Malignant Lung Diseases and Pathological Types of Lung Cancer

With the discovery of many tumor markers, there are new strategies for the early diagnosis and treatment of lung cancer and the prediction of prognosis. We examined the multi-protein markers panel (4MP, consisting of Pro-SFTPB, CA125, Cyfra21-1, and CEA) diagnosis performance in differentiating beni...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Lige, Li, Yanli, Wang, Qin, Chen, Tian, Li, Jiayin, Wang, Yingjie, Zhang, Liuyan, Su, Li, Li, Lanqing, Lou, Qinqin, Li, Fang, Zhao, Jiali, Gao, Junli, Gao, Junshun, Li, Huiqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355209/
https://www.ncbi.nlm.nih.gov/pubmed/37476198
http://dx.doi.org/10.7150/jca.85846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355209/
https://www.ncbi.nlm.nih.gov/pubmed/37476198
http://dx.doi.org/10.7150/jca.85846

Ejemplares similares